baber/WOPTO huggingface dataset:
Patent EP-0511357-B1 (EP)
Title: Sicherungsvorrichtung für eine um eine achse verschwenkbare bzw. drehbare vorrichtung
Inventor: GARTNER FRITZ
IPC: E05C17/52
Filed: 1991-11-19
Granted: 1995-03-15
Abstract: Um das ungewollte Verschwenken bzw. Verdrehen einer um eine Achse (2) verschwenkbaren bzw. verdrehbaren Vorrichtung (4), insbesondere eines Türflügels oder einer Drehtür mit schwenkbaren Rotationsflügeln zu verhindern, wird eine Sicherungsvorrichtung vorgeschlagen, bei welcher eine um eine Achse (2) drehbare Anschlageinrichtung (6) mit einer teilelastischen, verschwenkbaren Halteeinrichtung (8) in Eingriff bringbar ist und ein Schwenken der Vorrichtung (4) verhindert, bis eine von der Anschlageinrichtung (6) auf die Halteeinrichtung (8) wirkende, vorbestimmte Kraft so gross ist, dass sich zumindest ein Teil der Halteeinrichtung (8) von der Anschlageinrichtung (6) wegschwenkt, um ein Verschwenken der Vorrichtung (4) zu ermöglichen.
Patent EP-0563421-B1 (EP)
Inventor: PFANNENMUELLER GERHARD
IPC: H03G3/00
Filed: 1992-03-31
Granted: 1997-06-04
Abstract: In a circuit arrangement with a switching amplifier (10), particularly for hearing aids, for limiting a pulse-duration-modulated signal (S3) which is formed from a low-frequency signal (S1) and a higher-frequency triangular signal (S2), the output signal which can be taken from the switching amplifier is to be limited with only little distortion and without reducing the gain. For this purpose, the pulse-duration-modulated signal (S3) is supplied to a circuit (5; 14; 18) which changes in the pulse-duration modulated signal (S3) the duration (D1, D2, D4) of individual pulses, the duration (D1, D2, D4) of which is greater than or/and less than a maximum or respectively minimum pulse duration (D3; D5), which can be predetermined by the circuit (5; 14; 18), and in which the pulse-duration-modulated signal (S5; S6) changed by the circuit (5; 14; 18) can be supplied as input signal to the switching amplifier (10). <IMAGE>
Patent EP-0519318-B1 (EP)
Inventor: HEHL KARL
IPC: B65G65/00
Filed: 1992-06-11
Granted: 1997-03-12
Abstract: 2.1. In the prior art, injection-moulded articles were filled in a filling station in the region of the injection-moulding machine and then transferred from the filling station to a pallet turret, which has a lift to receive transport units. The releasing of the individual pallets from the transport units takes place with relatively large design and programming outlay, since the transport units usually consist of stacks of pallets. By contrast, the present device should minimise the time for the change both of the pallets and of the transport unit consisting of one or more pallets without increasing the programming outlay. 2.2. To this end, the pallets 55 are individually supported in transport pallets 56. In addition, both during the removal of the pallet from and during transfer of the pallet into the pallet turret, the lift 53 is in a position which permits a transfer of the filled pallet at least at the same place on the transport unit T,T' at which the pallet was removed from this transport unit. 2.3. Removing injection-moulded articles from a plastic injection-moulding machine. <IMAGE>
Patent EP-0529616-B1 (EP)
Inventor: SAKAI KUNIHIRO
IPC: G11B9/00
Filed: 1992-08-27
Granted: 2002-01-30
Abstract: An information processing apparatus for effecting recording of information on and/or reproduction of information from a recording medium is provided with a probe electrode, a cantilever piezo-electric member, a controller and a detector. The probe electrode is relatively displaced to the recording medium by the cantilever piezo-electric member. The controller applies a control signal to the cantilever piezo-electric member to control the cantilever piezo-electric member. The detector detects a minute signal obtained on the tunnel effect caused between the probe electrode and the recording medium. A switch element is further provided on the apparatus so as to electrically disconnect between the cantilever piezo-electric member and the controller during the minute signal being detected by the detector. <IMAGE>
Patent EP-0538822-B1 (EP)
Inventor: TURNER RAYMOND L
IPC: B23K35/363
Filed: 1992-10-21
Granted: 2001-07-25
Abstract: A non-toxic, non-corrosive foaming soldering flux (14) comprises citric acid and water, together with at least one foaming agent. The foam is fast-breaking, dissipating almost immediately. Such a fast-breaking foam is novel in an aqueous-based flux. The unique flux of the invention produces solder joints of high metallic luster and excellent quality. Disposal presents no health hazards, and clean-up of flux residues is accomplished using only water and, optionally, a surfactant. <IMAGE>
Patent EP-0521549-B1 (EP)
Inventor: CAIN FREDERICK WILLIAM
IPC: A23G1/36
Filed: 1992-06-24
Granted: 1995-08-23
Abstract: The presence of a specific (H2M + HM2)-fat, either in the filling or in the coating of encapsulated fillings, results in the retardation of bloom of the chocolate composition. Therefore, the invention is concerned with encapsulated fillings, wherein the coatings display a defined (H2M + HM2)-content. A process of preparing these encapsulated products is also disclosed. Encapsulated products are, e.g., chocolates, pralines, biscuits, cookies, toffees, fried snacks or cakes.
Patent EP-0551746-B1 (EP)
Inventor: SJOQUIST STEVEN E
IPC: A61N1/37
Filed: 1992-12-16
Granted: 1998-07-22
Abstract: A defibrillator/monitor (10) is disclosed employing a motion detection circuit 18 and control and processing circuit (20) that cooperatively detect motion at a patient-electrode interface. In that regard, an impedance measurement circuit (24) produces an output indicative of the impedance of the interface. This output is then processed by a number of filter elements before being analyzed by a motion detection routine (52). The motion detection routine includes subroutines (62 and 64) that compare the impedance against distinct upper and lower limits and then monitor the time at which the signal is above and below the limits. Basically, motion is indicated if the signal undergoes relatively large variations for a short time, or smaller variations for a longer time. A third motion clear subroutine (66) is used to determine when motion is no longer detected. Finally, a similar scheme (102) is employed to quickly restore the various filter elements after saturation. <IMAGE>   <IMAGE>
Patent EP-0563262-B1 (EP)
Title: Dispositif a orifice variable
Inventor: NAUGLE ROBERT A C O EASTMAN KO
IPC: F16L29/00
Filed: 1991-12-13
Granted: 1995-07-19
Abstract: Un dispositif à orifice variable (20) laissant passer un matériau fluide sous pression comprend un élément (30) réalisé dans un matériau résilient qui est courbé à partir de sa forme normale de sorte qu'une première surface soit en condition étirée et qu'une deuxième surface soit en condition comprimée. Une fente (32) s'étend entre les deux surfaces (40, 42). Etant donné la différence des états contraints des deux surfaces (40, 42), l'une étant étirée, l'autre comprimée, une extrémité de la fente (32) est ouverte alors que 'autre extrémité, située au niveau de la surface comprimée se trouve en condition fermée par contrainte. L'élément (30) en matériau résilient est monté, alors qu'il est courbé par contrainte, sur un cadre qui supporte ledit matériau dans sa condition courbée. L'élément (30) en matériau résilient peut être découpé dans un tuyau en caoutchouc au silicone (36) tel que celui qu'on utilise pour des pompes péristaltiques. Le cadre peut être formé de deux éléments annulaires (34); le premier de ces éléments étant fixé par ajustage dans le deuxième élément qui comprend lui-même un épaulement annulaire (28) contre lequel un disque (30) en matériau résilient est bloqué et scellé par le premier élément annulaire.
Patent EP-0570405-B1 (EP)
Inventor: KUSCHEL ANNEGRET
IPC: C09K23/16
Filed: 1992-02-04
Granted: 1995-05-24
Abstract: Disclosed are cosmetic preparations containing mixtures of (a) zinc salts and (b) glycine and/or (c) one or more zinc salts of glycine. Also disclosed is the use of mixtures of (a) zinc salts and (b) glycine and/or (c) one or more zinc salts of glycine, as the main ingredient providing protection against physical deterioration of water-in-oil emulsions.
Patent EP-0571420-B1 (EP)
Inventor: CONTENT JEAN
IPC: C12Q1/689
Filed: 1992-02-07
Granted: 1997-05-28
Abstract: The invention relates :   to nucleic acids which contain particularly a nucleotide sequence extending from the extremity constituted by the nucleotide at position (1) to the extremity constituted by the nucleotide at position (149) represented on Figure 1,   to the polypeptides coded by said nucleic acids.   The polypeptides of the invention can be used for the diagnosis of tuberculosis, and can also be part of the active principle in the preparation of vaccine against tuberculosis. <IMAGE>
Patent EP-0531545-B1 (EP)
Inventor: FUKUDA HIDEO
IPC: C08L15/00
Filed: 1992-03-27
Granted: 1997-07-30
Abstract: Est décrite une composition de caoutchouc covulcanisable comprenant un copolymère diène conjugué/nitrile partiellement hydrogéné, un copolymère éthylène/propylène chloré et un agent de vulcanisation. La composition donne un excellent vulcanisat avec une résistance constante à la fatigue par étirage et une bonne aptitude au mélageage tout en conservant d'excellentes résistances à la chaleur et aux huiles comme un vulcanisat préparé à partir d'un copolymère diène conjugué/nitrile insaturé partiellement hydrogéné et d'un copolymère d'éthylène/propylène.
Patent EP-0530354-B1 (EP)
Inventor: OBEL ISRAEL
IPC: A61N1/365
Filed: 1992-03-18
Granted: 1997-12-29
Abstract: Procédé et dispositif servant à stimuler les nerfs droits et/ou gauches des sinus de la carotide ou le ganglion stellaire droit ou l'espace épidural sur environ T2 au moyen d'impulsions électriques continues et/ou phasées en réaction à une ischémie myocardique détectée, afin de réduire la charge de l'activité cardiaque en tant que procédé de protection du myocarde. La détection automatique de la nécessité d'une telle stimulation se fait par réaction à une modification intervenant dans la variation du segment ST différente d'un seuil prédéterminé ou programmé suggérant une ischémie myocardique aigüe et/ou d'autres critères ou indicateurs d'une ischémie myocardique, y compris des modifications du pH et/ou de la saturation en oxygène (SO2) détectées par un détecteur placé dans le c÷ur, de préférence dans le sinus coronaire. Le système est mis en application au moyen d'un stimulateur cardiaque à double chambre pourvu de capacités de programmation et de télémétrie servant à enregistrer automatiquement dans une mémoire les valeurs susmentionnées pendant des périodes précédant et suivant chaque phase de stimulation, pour arrêter la télémétrie sur commande et pour programmer le démarrage d'un ou plusieurs détecteurs.
Patent EP-0589948-B1 (EP)
Inventor: HONKANEN ERKKI
IPC: C07C205/44
Filed: 1992-06-18
Granted: 1996-09-04
Abstract: PCT No. PCT/FI92/00192 Sec. 371 Date Jan. 6, 1994 Sec. 102(e) Date Jan. 6, 1994 PCT Filed Jun. 18, 1992 PCT Pub. No. WO93/00323 PCT Pub. Date Jan. 7, 1993.A method for the preparation of 3,4-dihydroxy-5-nitrobenzaldehyde by reacting 4-hydroxy-3-methoxy-5-nitrobenzaldehyde with a strong nucleophilic agent which may be created by reacting an aromatic mercapto compound with a strong organic or inorganic alkali metal base such as lithium hydroxide. The reaction is performed at elevated temperatures using an aprotic polar solvent. It is preferably carried out in an inert atmosphere.
Patent EP-0599974-B1 (EP)
Title: Agent gonflant et procede de preparation de mousse de polyurethanne
Inventor: BARTLETT PHILIP LEE
IPC: C08J9/14
Filed: 1992-08-19
Granted: 1999-04-28
Abstract: L'invention décrit l'utilisation de 1,1-difluoroéthanne (HFC-152a) et de diméthyl éther, éventuellement jusqu'à 50 % en moles d'eau, comme agent gonflant pour produire de manière efficace une mousse rigide de polyisocyanurate ou polyuréthanne à cellules fermées ayant une structure cellulaire améliorée et d'excellentes propriétés d'isolation.
Patent EP-0593685-B1 (EP)
Inventor: LEE HONGPYO H
IPC: A61M25/06
Filed: 1992-07-06
Granted: 2000-02-16
Abstract: The invention relates to an apparatus for use for vascular implantation of a lead or catheter comprising a separable introducer sheath (12) adapted for disposition within a body lumen; a separable hemostatic valve (14) coupled to said introducer sheath (12), said hemostatic valve (14) for sealing said lead or catheter within said hemostatic valve (14) to prevent bleeding or introduction of air into said body lumen when said lead or catheter is introduced into said body lumen; characterized in that the apparatus comprises means for permitting removal of said separable introducer sheath (12) and said separable hemostatic valve (14) from said lead or catheter without sliding either said separable introducer sheath (12) or said separable hemostatic valve (14) over said lead or catheter; and means for separating said separable introducer sheath (12) and said separable hemostatic valve (14) in a controlled and predictable manner to permit removal from said lead or catheter. <IMAGE>
Patent EP-0607354-B1 (EP)
Inventor: OUDET CLAUDE
IPC: H01F7/122
Filed: 1992-10-09
Granted: 1996-03-20
Abstract: La présente invention concerne un actionneur électromagnétique comportant une structure statorique réalisée en un matériau magnétique doux non saturable en régime nominal, comportant deux parties statoriques (1 et 2), l'une ou moins des structures statoriques (1) présentant un pôle central (5) de longueur YC et deux pôles latéraux (6, 7) de longueur YL, lesdites parties statoriques (1, 2) délimitant un entrefer E à l'intérieur duquel est disposé un organe rotorique mobile comportant deux paires de pôles de longueur YR constitués par des aimants minces permanents (10 et 11) aimantés transversalement, caractérisé en ce que la longueur YC du pôle statorique central (5) est supérieure ou égale à la course Y de l'organe mobile rotorique augmentée d'une longueur sensiblement égale à la longueur E de l'entrefer, la longueur YL des pôles latéraux (6, 7) étant déterminée par le volume occupé par la bobine électrique d'excitation en fonction de la force par puissance électrique appliquée et de l'épaisseur Z de ladite bobine, l'épaisseur Z étant mesurée selon un axe perpendiculaire au plan des aimants minces (10, 11), la longueur YL des pôles latéraux (6, 7) étant supérieure à la longueur YC du pôle central (5).
Patent EP-0581327-B1 (EP)
Inventor: HODDER JAMES JOHN
IPC: C14C3/22
Filed: 1992-02-05
Granted: 1996-11-20
Abstract: A method for treating leather with a low fogging, substantive, retan fatliquor containing a solution or a dispersion of a selected amphiphilic copolymer, substantially free from organic solvents, formed from a predominant amount of at least one hydrophobic monomer and a minor amount of at least one copolymerizable hydrophilic monomer. The method produces leather having desirable strength and softness qualities and particularly reduced fogging characteristics. The treated leather is particularly suitable for use in vehicle upholstery.
Patent EP-0590626-B1 (EP)
Inventor: ORTNER HERBERT DR
IPC: D21B1/32
Filed: 1993-09-29
Granted: 1996-02-21
Abstract: The invention relates to a process for treating printed waste paper, in particular waste paper which contains at least 80% of newspapers or magazines, by disintegration, various purification stages, flotation or washing and defibration, the latter at a high consistency of at least 20%, and bleaching if necessary. The invention is characterised in that a final second defibration stage, located upstream of a bleaching stage if any, is carried out by treatment of the waste paper with strong kneading action of singular, rod-shaped or block-shaped kneading elements of both the stator and rotor of the defibration machine, which are arranged in a kneading chamber thereof which is bounded by two concentric cylinder surfaces, at temperatures of between 20 and 110 DEG C, preferably 38 to 65 DEG C, and a specific energy consumption of between 30 and 100, preferably 80, kWh/tonne of dry matter. <IMAGE>
Patent EP-0559280-B1 (EP)
Title: Gas dosing device
Inventor: WOLTERING HERMAN JOSEF
IPC: F23N5/20
Filed: 1993-02-26
Granted: 1997-12-03
Abstract: The invention relates to a gas dosing device comprising a flow duct which is connected to a flow generating device such as a fan and has an inlet end for a main gas flow and an outlet end. The flow duct is divergent in the through-flow direction and a main gas valve element extending transversely of the duct is accommodated therein guided for movement coaxially of the duct. The main gas valve element is loaded in the direction counter to the through-flow direction and is connected to a mixing gas dosing unit which is connected to a mixing gas feed pipe and can deliver an amount of mixing gas related to the position of the main gas valve element in the duct. The invention further relates to a heating device (1) comprising means defining a flow duct (2) which is connected to a fan (6) and has successively in a through-flow direction at least a gas dosing device (3) as described above, a burner (4) and a heat exchanger (5) through which a heat transfer medium can flow. The inlet end of the gas dosing device is connected to the atmosphere and the mixing gas feed pipe is connected to a source of flammable gas. <IMAGE>
Patent EP-0618995-B1 (EP)
Inventor: GROFFE JACQUES
IPC: C10L10/04
Filed: 1992-12-22
Granted: 1998-04-29
Abstract: The invention relates to the use of(A) esters of phosphoric acid and/or partial salts thereof with alkoxylated aliphatic, cycloaliphatic and/or aromatic alcohols and/or(B) fatty acid oligo-dialkanolamides as inhibitors against the formation of incrustations based on organic solids from liquid and/or gaseous hydrocarbon mixtures which are fluid and prone to form such incrustations. Preferred inhibitors having a surface-active character are capable of wetting, and especially of spreading on, solid work material surfaces also in the presence of the fluid hydrocarbon phase. They are particularly suitable as additives to crude oils and/or oil fractions susceptible of forming incrustations.
Patent EP-0623000-B1 (EP)
Inventor: FAHY ARTHUR J
IPC: A47L13/12
Filed: 1993-01-21
Granted: 1996-12-18
Abstract: PCT No. PCT/AU93/00023 Sec. 371 Date Jun. 8, 1994 Sec. 102(e) Date Jun. 8, 1994 PCT Filed Jan. 21, 1993 PCT Pub. No. WO93/14686 PCT Pub. Date Aug. 5, 1993.A car-cleaning implement (1) comprises a spongy resiliently-flexible liquid-absorbent block (2) having an exposed face (3) for applying soapy water, and its opposite face sheathed with a thin flexible skin (4) which is not water absorbent and is formed with parallel ribs (5) extending between opposite ends of the block. By inverting the block after washing off the soapy water, the ribbed skin can be used to remove water droplets from the painted surface of the car without streaking.
Patent EP-0579813-B1 (EP)
Inventor: GIHSLER WALTER
IPC: H04Q11/04
Filed: 1993-01-29
Granted: 2003-09-10
Abstract: Described is a bit oriented digital switch comprising means (SPM1, ..., SPM8; WSW1, ..., WSW8; WCM1, ..., WCM8; WM1, ..., WM8; BSW1, ..., BSW8; BCM1, ..., BCM8; BM) for controlled change of bit position and PCM word of chosen bits and bit groups in PCM words received by the switch. The switch is suitable to combine with a conventional word oriented switch to allow flexible switching of both entire PCM words and parts thereof. This switch also makes it possible to define a digital PCM transmission system, in which PCM words can contain one or several traffic channels and in which traffic channels that occupy a bit group containing at least one bit, but not an entire PCM word, dynamically are allocated necessary space at an arbitrary available location in PCM words.
Patent EP-0675966-B1 (EP)
Inventor: CHETVERIN ALEXANDER B
IPC: C12Q1/68
Filed: 1993-02-19
Granted: 2004-10-06
Abstract: The invention relates to a nucleic acid analytical device, and a support, and their use for sorting, isolating, sequencing, and manipulating nucleic acids. Binary oligonucleotide arrays, having binary oligonucleotides characterized by a constant nucleotide sequence adjacent to a variable nucleotide sequence, are used for sorting and surveying nucleic acid strands. Oligonucleotide arrays are used for sorting mixtures of nucleic acid strands, making immobilized partial copies of nucleic strands, ligating strands, or introducing site directed mutations into strands. Information is obtained for determining the sequence of a nucleic acid strand, alone or in a mixture, by generating partials of the strand and, for groups of partials having the same terminal variable oligonucleotide, separately determining the presence and sequence of all variable oligonucleotides. Arrays are also used to order previously sequence nucleic acid fragments and to allocate ordered allelic fragments to chromosomal linkage groups.
Patent EP-0651768-B1 (EP)
Inventor: JEFFERIES WILFRED A
IPC: A61K38/00
Filed: 1993-07-09
Granted: 2001-11-07
Abstract: The invention relates to a GPI-anchored p97 and a soluble form of p97 and derivatives thereof and methods for preparing the same. Methods of using p97 in modulating iron transport, in the delivery of therapeutic agents, and in the treatment of conditions involving disturbances in iron metabolism are described. The treatment and diagnosis of Alzheimer's Disease in view of the finding that p97 and transferrin receptor are markers for microglial cells associated with senile plaques are also described.
Patent EP-0619117-B1 (EP)
Inventor: MCANALLEY BILL H
IPC: C08B37/00
Filed: 1989-08-03
Granted: 2000-05-10
Abstract: The use of acemannan for the manufacture of a medicament for the production of a defective virus and a method of producing a defective virus in master seed cultures for vaccine production comprising the addition of a pharmaceutically effective amount of acemannan to a master seed culture to produce altered viral replication are described.